Fund
BVF Partners
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 2
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 9 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 09 Sept | United States, Biotech | 50 M$ | Lead | |
| 03 Sept | United States, Biotech | Series B | 60 M$ | Lead |
| 06 Feb | United States, Biotech | Series D and later | 130 M$ | Participant |
Co investors 22 funds crossed
- Eli Lilly and Company 2 operations
- RA Capital Management 2 operations
- Ascenta Capital 1 operation
- Bain Capital Life Sciences 1 operation
- BlackRock 1 operation
- Catalio Capital Management 1 operation
- Cooley 1 operation
- Deep Track Capital 1 operation
- Frazier Life Sciences 1 operation
- Gaingels 1 operation
- Hillhouse Investment 1 operation
- Insight Partners 1 operation
- Invus 1 operation
- JDRF T1D Fund 1 operation
- Kura Oncology 1 operation
- Logos Capital 1 operation
- Montanova 1 operation
- NVIDIA 1 operation
- OrbiMed 1 operation
- Perceptive Advisors 1 operation
- Venrock Healthcare Capital Partners 1 operation
- Wellington Management 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.